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Background: Angiostrongylus cantonensis, the rat lungworm, is the major cause of eosinophilic meningitis
worldwide. Rats serve as the definitive host of the nematode, but humans can be infected incidentally, leading to
eosinophilic meningitis. A previous BALB/c animal study has demonstrated increased apoptotic proteins and decreased
anti-apoptotic proteins in mice infected with A. cantonensis. Steroids may be an effective treatment option for eosinophilic
meningitis caused by A. cantonensis, but the involved mechanism is unclear. This study hypothesized that the beneficial
effects of steroids on eosinophilic meningitis are mediated by decreased apoptosis.
Methods: In a BALB/c animal model, mice were orally infected with 50 A. cantonensis L3 via an oro-gastric tube and were
sacrificed every week for 3 consecutive weeks after infection or until the end of the study. Dexamethasone was injected
intra-peritoneally from the 7th day post-infection until the end of the 21-day study. Evans blue method was used to
measure changes in the blood brain barrier, while western blotting, immuno-histochemistry, and TUNEL assay were used
to analyze brain homogenates expression of apoptotic and anti-apoptotic proteins.
Results: There were increased amounts of Evans blue, apoptotic proteins (caspase-3, -8, and -9 and cytochrome C), and
decreased anti-apoptotic proteins (bcl-2) after 2-3 weeks of infection. Dexamethasone administration significantly
decreased Evans blue extravasations and apoptotic protein expressions.
Conclusions: Apoptosis of mice brain homogenates can be repressed by dexamethasone treatment.
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Angiostrongylus cantonensis, also known as rat lung-
worm, is the most common cause of eosinophilic menin-
gitis worldwide. This parasitic infection is endemic in
the Southeast Asian and Pacific regions [1-4] and the
intermediate hosts are fish and snails [5-8]. The typical
clinical presentation is acute meningitis, with an eosino-
philic pleocytosis. The pathological findings in the cen-
tral nervous system (CNS) include meningitis with a
predominance of eosinophils and plasma cells; tortuous
tracks of various sizes in the brain and spinal cord sur-
rounded by an inflammatory reaction and degenerating* Correspondence: hctsai1011@yahoo.com.tw; yschen@vghks.gov.tw
1Section of Infectious Diseases, Department of Medicine, Kaohsiung Veterans
General Hospital, Kaohsiung, Taiwan and National Yang-Ming University,
Taipei, Taiwan
3National Defense Medical Center, Taipei, Taiwan
Full list of author information is available at the end of the article
© 2015 Tsai et al.; licensee BioMed Central. Th
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.neurons; granulomatous response to the dead parasites;
and non-specific vascular reactions, including thrombosis,
vessel rupture, arteritis, and aneurysm formation [9]. How-
ever, changes in inflammatory cytokines and specific anti-
body to A. cantonensis after infection, as well as the
mechanism of blood brain barrier damage, remain unclear.
A previous study has shown that eosinophilic meningi-
tis caused by A. cantonensis in infected mice, with acti-
vation of the apoptosis pathway in leukocytes infiltrating
the subarachnoid space [10]. Steroids have been pro-
posed as adjunct treatment [11,12], but how the apop-
tosis process is regulated in the brain parenchyma and
roles of steroid administration are also unknown.
Using a BALB/c mice model, this study hypothesized
that the treatment effect of steroids in eosinophilic men-
ingitis is mediated by the down-regulation of apoptosis.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Ethics statement
The animal studies were conducted in strict accordance
with the recommendations from Taiwan’s Animal
Protection Act. The Animal Committee of Kaohsiung
Veterans General Hospital approved the study protocol.
Infection of BALB/c mice and intra-peritoneal steroid
injection
Forty BALB/c mice aged 6-7 weeks were purchased from
the National Laboratory Animal Breeding Research
Centre. They were raised and maintained in an air-
conditioned animal facility (25 ± 2°C and 50 ± 10% rela-
tive humidity). Third-stage larvae of A. cantonensis were
harvested from infected Biomphalaria glabrata after
treatment with artificial gastric juice (pepsin, 2 g; con-
centrated HCl, 7 mL; and distilled water, 1 L) as previ-
ously described [13]. The mice were orally infected with
50 A. cantonensis L3 via an orogastric tube after slight
ether anesthesia. Eight mice were sacrificed every week
for 3 consecutive weeks after infection (end of the
study). Dexamethasone (500 ug/kg/day) was injected
intra-peritoneally from 7th post-infection day until the
end of the study. All animal experiments were approved
by the Institutional Animal Care and Use Committee.
Measurement of permeability of the blood–brain barrier
by Evans blue method
A volume of 200 μL of 2% (w/v) solution of Evans blue in
PBS was injected into the tail vein of each mouse. The
mouse’s brain was removed one hour later, after anesthesia
with ketamine, which was ground with 1.0 mL PBS in a
glass-tissue grinder using a Teflon pestle. The extract was
then centrifuged at 18,000 × g (Hermle, Z326K, Germany)
for 10 min at room temperature. The optical density of
the supernatant was read at 595 nm wavelength using a
colorimeter (Thermo Scientific Multiskan FC, USA).
Western blotting
The mouse brain extracts were centrifuged at 12,000g
for 20 min in 4°C to remove the debris. Protein concen-
tration was analyzed using a protein assay kit (Bio-Rad,
Hercules, CA, USA) with BSA as the standard. Briefly,
50μg protein were separated by 10% SDS-PAGE and
transferred to PVDF membranes. The membranes were
incubated in blocking buffer for 60 min (PBS containing
5% BSA) at room temperature. The membranes were
then washed three times with PBST and probed with
caspase-3, -8, and -9 and Bcl-2 and cytochrome C with
β-actin (Sigma, St. Louis, MO, USA) as control. After in-
cubation with secondary antibody, detection was made
by enhanced chemi-luminescence method. Quantitative
analysis of the bands was performed using a computer-
assisted imaging densitometer system, UN-SCAN-IT™.Immuno-histochemistry
Immuno-histochemistry was performed to detect apop-
totic proteins on brain sections. Briefly, paraffin-
embedded sections (4 μm) were de-paraffinized, treated
with 3% H2O2 in methanol for 10 min to inactivate any
endogenous peroxidase, and washed with PBST (0.1%
Tween 20 in PBS). The sections were then blocked for
60 min in blocking buffer (10% bovine serum albumin
[BSA] in PBS), followed by a 60 min incubation with
rabbit polyclonal IgG and rabbit monoclonal IgG in 1%
BSA. The sections were each washed three times for 10
min in PBST, followed by 60 min incubation with HRP-
conjugated secondary antibody (Novolink™ polymer de-
tection kits) at room temperature. The sections were
then incubated for 10 sec-1 min at room temperature
with 3,3’-diaminobenzidine (DAB) for color develop-
ment, and then counterstained with diluted hematoxylin.
Terminal deoxynucleotidyltransferase-mediated dUTP
nick-end labeling (TUNEL) assay
Cells undergoing apoptosis generate free DNA ends that
were labeled in situ using terminal deoxynucleotidyl-
transferase (TdT) by incorporating an exogenously
added, labeled nucleotide into the DNA strand. In situ
Death Detection Kits (Roche, Mannheim, Germany) de-
tect apoptotic cells by specific staining. TUNEL assay
was used to determine brain cell apoptosis. Briefly, brain
sections on cover slips were de-paraffinized and washed
with PBS. Sections were treated with 3% H2O2 in metha-
nol for 10 min to inactivate endogenous peroxidase and
washed three times with PBS for 5 min. The DNA frag-
ments were labeled with the TUNEL mix fluorescence
for 1 hour than washed three times with PBS for 5 min.
The sections were incubated in DAPI for 10 min and
observed by fluorescence microscopy.
Statistical analysis
The Mann Whitney U test was used to compare changes
in apoptotic and anti-apoptotic proteins, and in Evans
blue amounts every week in relation to controls or ster-
oid treatment. Statistical significance was set at p < 0.05.
Results
Permeability of the blood-brain barrier by Evans
blue method
After infection, the brains of infected mice showed vary-
ing degrees of staining by Evans blue. The quantities of
Evans blue in the homogenates of the brain gradually in-
creased 14 days post-infection until the end of this study
(21 days post-infection). The amount of Evans blue in
the mice brain showed significant increase 3 weeks after
infection compared to those of uninfected mice (p <
0.05). Administration of dexamethasone for 2 weeks sig-
nificantly decreased the intensity of Evans blue in the
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weeks after infection (Figure 1).
Western blot analysis of apoptotic protein concentrations
in the brain homogenates of mice
Western blot analysis for apoptotic protein in brain ho-
mogenates (Figure 2) revealed that apoptotic proteins
caspase-8, -3, and -9 and cytochrome C increased post-
infection. There was also a significant increase in
caspase-3 and -8 and in cytochrome C protein 2-3 weeks
post-infection compared to the controls and levels at 1
week post-infection. Dexamethasone administration sig-
nificantly decreased caspase-9 and cytochrome C protein
expressions. However, there was no effect on the expres-
sion of Bcl-2 protein compared to levels within the first
three weeks post-infection.
Immuno-histochemistry (IHC) staining of apoptotic
protein in the meninges of mice brain
The IHC study for apoptotic protein in brain meninges
(Figure 3) revealed an increase of apoptotic protein
amounts in the 2nd and 3rd week post-infection compared
to the controls and at 1 week post-infection in both the
cerebrum and cerebellum. Dexamethasone administration
significantly decreased apoptotic protein expressions.
However, the decrease in expressions of apoptotic proteins
in the brain meninges was specific and not every protein
had a similar decrease after steroid administration.
TUNEL assay in the subarachnoid space and meningeal
area of mice infected with A. cantonensis
Brain tissues were harvested from BALB/c mice 1-3




















Figure 1 The amount of Evans blue staining in the mice brain
significantly increased at 3 weeks post-infection compared to
those of uninfected mice (p = 0.03). Dexamethasone administration
for 2 weeks (7th–21st day post-infection, group 3W +D) significantly
decreased the intensity of Evans blue staining compared to those of
mice at 3 weeks post-infection, which had the most serious damage to
the blood-brain barrier (p = 0.025).2 weeks post-infection, with third stage larvae of A. can-
tonensis, and then analyzed by TUNEL staining at differ-
ent weeks of infection. Immuno-fluorescence TUNEL
(green) and DAPI (blue) were used to stain the apoptotic
cells. In the cerebrum and cerebellum, TUNEL stain was
near maximal on the 3rd week post-infection. Dexa-
methasone administration decreased cell apoptosis com-
pared to the first three weeks infection (Figure 4).
Discussion
This study reveals an increase in brain apoptotic protein
expressions and blood-brain barrier damage as demon-
strated by increase Evans blue extravasations following
2-3 weeks of infection with third stage larvae of A. can-
tonensis. Steroid administration remarkably decreases
the Evans Blue staining and apoptotic protein expres-
sions. These findings provide evidences supporting the
effects of steroids on A. cantonensis infection.
Steroids have been proposed as adjunctive treatment
for eosinophilic meningitis. In the clinical observations
of Chotmongkol et al. [11], a two-week course of pred-
nisolone is beneficial in relieving headaches in patients
with eosinophilic meningitis. In the study of Sawanyawi-
suth et al. [12], a one-week course of corticosteroid
treatment is also effective. Steroids may improve capil-
lary function by reducing the activity of urokinase-type
plasminogen activators and matrix metalloproteinase 9,
and increasing the levels of matrix metalloproteinase tis-
sue inhibitors [14]. The use of dexamethasone in mice
with eosinophilic meningitis caused by A. cantonensis in-
fection can partially inhibit the activity of plasminogen
activators and inflammation [15].
Treatment of eosinophilic meningitis with corticoste-
roids can also relieve intracranial pressure and improve
neurologic symptoms due to inflammatory responses to
migrating and dying worms [16]. IL-5 can regulate the
proliferation, differentiation, and activation of eosino-
phils [17] in parasitic meningitis, and provide a signal
for the mobilization of eosinophils from the bone mar-
row [18]. Steroids can suppress the inflammatory gene
transcriptions of interleukin-3, interleukin-4, GM-CSF,
and various chemokines, thereby decreasing the survival
of eosinophils [19]. Taken together, the beneficial effects
of steroids on eosinophilic meningitis caused by A. can-
tonensis infection are possibly mediated by the down-
regulation of apoptotic protein expressions in the CSF,
improvement of blood-brain barrier dysfunction, inhib-
ition of the activity of plasminogen activators and in-
flammation, and the inhibition of cytokine-dependent
eosinophil survival, among others.
The term apoptosis was first coined in 1972 and has
since been generally applied to programmed cell death,
where cells die by an active process characterized by nu-
clear fragmentation and cell shrinkage, while maintaining
Figure 2 By Western blotting, there were significant increases in caspase-3, -8, and -9 and in cytochrome C proteins in the 2nd and 3rd
weeks post-infection compared to the controls and on the 1st week post-infection. Dexamethasone administration significantly decreased
the expression of cleaved caspase-3, -8, and -9 and cytochrome C proteins. Control: no parasitic infection; 1W: one week after infection; 2W: two
weeks after infection; 3W: three weeks after infection; 3W + Dex: mice given dexamethasone for 2 weeks (7th–21st day post-infection) and
sacrificed on day 21.
Figure 3 By immuno-histochemistry (IHC), there was an increase in apoptotic protein expressions in the brain meninges on the 2nd
and 3rd weeks post-infection compared to the controls and on the 1st week post-infection in both the cerebrum and cerebellum.
Dexamethasone administration significantly decreased the expressions of apoptotic proteins. Scale bar, 10 um at 10x and 40x magnification.
Tsai et al. Parasites & Vectors  (2015) 8:200 Page 4 of 7
Figure 4 TUNEL assays of brain apoptosis in mice infected with A. cantonensis revealed increased apoptosis 3 weeks post-infection.
Steroids significantly decreased this apoptosis.
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by two major pathways. One is called the “extrinsic” path-
way, triggered by ligation of trans-membrane death recep-
tors belonging to the tumor necrosis factor (TNF)
receptor super-family [21]. The other one is the “intrinsic”
pathway, mainly regulated by the interplay of pro- and
anti-apoptotic members of the B cell lymphoma 2 (Bcl-2)
family at the level of the mitochondria [22]. This is initi-
ated by cytotoxic drugs, intracellular stress, growth-factor
deprivation, and hormones that cause the activation of
pro-apoptotic Bcl-2 family members [23] and subse-
quently, the release of cytochrome c from the mitochon-
dria. Together with Apaf-1 and procaspase-9, this results
in the formation of the “apoptosome”, a multimeric com-
plex that activates caspase-3.
The interaction between pro- and anti-apoptosis factors
in the brain has important regulatory functions in the
patho-physiologic process, including the development of
neuronal ischemic infarction after both global and focal is-
chemia [24-26]. In chronic neurodegenerative diseases like
Alzheimer’s disease, amyotrophic lateral sclerosis, Parkin-
son’s disease, and Huntington’s disease, and in acute or
sub-acute pathologic conditions such as ischemia, toxins,
trauma and infection, apoptosis causes significant neur-
onal loss through these processes [27-29].
Apoptosis is also essential for the growth and sur-
vival of most multi-cellular organisms [30]. In a mice
model of parasitic eosinophilic meningitis caused by A.
cantonensis infection, Chen et al. have identified in-
creased infiltrations of leukocytes in the brain paren-
chyma and in the subarachnoid space, as well as
apoptosis 15-25 days after mice are infected with third
stage larvae of A. cantonensis [10]. In the study of Hu
et al., the larvae extracts of A. cantonensis can induce
apoptosis in primary culture brain micro-vascular
endothelial cells and in brain astrocytic cells, and par-
ticipate in blood-brain barrier dysfunction [31].
Chuang et al. used ICR mice as a parasitic eosinophilic
meningitis model to show that apoptosis of inflamma-
tory cells can be induced when the infected mice are
treated with Mebendazole and/or IL-12 [32]. The
model of steroid-induced cell death assumes that vari-
ous pro- and anti-apoptotic Bcl-2 family members are
implicated in steroid induced apoptosis [33].
The over-expression of the anti-apoptotic family mem-
bers Bcl-2 or Bcl-XL prevents steroid-induced apoptosis,
whereas the combined disruption of the pro-apoptotic
proteins Bax and Bak results in complete resistance to
steroid-induced cell death [34]. Several caspases have
been proposed to be necessary for apoptosis induction
by steroids. Data obtained in the MOG-EAE model in
C57Bl ⁄ 6 mice further suggest that steroids primarily in-
duce apoptosis in peripheral T cells, whereas cell death
in the CNS appears to be a secondary event [35].In the present study, dexamethasone is associated with
the inhibition of apoptosis instead of the induction of
apoptosis. This discrepancy may be due to several reasons.
First, this study was in vivo and previous studies were
mostly in vitro cell model. Second, different strains of
mouse (BALB/c vs. C57BL/6) were used. Third, different
disease models for steroid use were also involved here.
Lastly, the dosage, routine of administration, and duration
(2 weeks) were different in different disease models.
Conclusion
Apoptosis of mice brain homogenates can be repressed by
treatment with dexamethasone. The findings here demon-
strate one mechanism of action of corticosteroids in the
treatment of A. cantonensis eosinophilic meningitis.
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